SuperworthENDRA Life Sciences shares outstanding NDRA
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Jun 30, 2026
- 2.5M
- On a year earlier
- +245.2%
- more shares
ENDRA Life Sciences had 2.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 245.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.1M | +106% |
| FY2024 | 537.2K | +10910% |
| FY2023 | 4.9K | +170% |
| FY2022 | 1.8K | +718% |
| FY2019 | 221 | +24% |
| FY2018 | 178 | +59% |
| FY2017 | 112 | +441% |
| FY2016 | 21 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 2.5M | +245% | |
| Q1 FY26 | 1.2M | +115% | |
| Q4 FY25 | 1.1M | +106% | |
| Q3 FY25 | 761.2K | +208% | |
| Q2 FY25 | 717.1K | +4500% | |
| Q1 FY25 | 557.6K | +8931% | |
| Q4 FY24 | 537.2K | +10910% | |
| Q3 FY24 | 246.8K | −94% | |
| Q2 FY24 | 15.6K | +355% | |
| Q1 FY24 | 6.2K | +241% | |
| Q4 FY23 | 4.9K | +170% | |
| Q3 FY23 | 4.4M | +243171% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on ENDRA Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.